DUBAI, February 12, 2026 – The four-day WHX Dubai 2026 (formerly known as Arab Health), one of the world’s most prestigious healthcare exhibitions, concluded today with record-breaking participation. This year’s event attracted over 4,300 exhibitors and 235,000 professional visitors from 180 countries. SLK Medical, a leading innovator in the Chinese wound care sector, made a significant impact by showcasing its core Alexer® series, tailored specifically for the clinical needs of the Middle East market.
Addressing Clinical Pain Points with Alexer® Innovation
At WHX Dubai, SLK Medical introduced a suite of targeted solutions designed to address the region’s rising demand for chronic wound management and post-surgical care:
-
Alexer® Silicone Foam Dressing: Utilizing advanced soft silicone adhesive technology, this dressing provides dual benefits of anti-adhesion and high exudate absorption. It is engineered for chronic wounds such as diabetic foot ulcers and pressure injuries, aligning perfectly with the region’s healthcare needs.
-
Alexer® Super Absorbent Dressing: This high-capacity solution rapidly locks in wound fluid, significantly reducing infection rates and dressing change frequency—a critical efficiency gain for surgical settings.
-
Alexer® Silicone Post-Op Dressing: Designed for the delicate needs of high-end private hospitals, this dressing offers exceptional breathability and flexibility for joint areas. It can be removed intact to prevent damage to newly formed granulation tissue.
-
Alexer® Silicone Scar Sheets: Built on the concept of moist wound healing, these sheets promote scar softening and are biocompatibility-certified for use even on sensitive skin.
Strategic Expansion into the Middle East Blue Ocean
With the Middle East wound healing market exceeding $1.8 billion in 2025—and Saudi Arabia, the UAE, and Israel accounting for 75% of that share—SLK Medical is positioning itself at the center of this 32% year-on-year growth sector.
“WHX Dubai serves as a vital hub for global medical trade,” stated a representative from SLK Medical’s overseas market division. “The surge in demand for high-quality wound care in this region is immense. We are deepening our partnerships with local agents to integrate the Alexer® series into national procurement systems, such as Saudi Arabia’s, bringing ‘Made-in-China’ intelligent medical solutions to more patients”.
During the event, SLK Medical reached multiple cooperation agreements with distributors from Saudi Arabia, the UAE, and Qatar, significantly accelerating its regional market presence.
Technology-Driven Core Competitiveness
SLK Medical has spent years refining its production processes to cover the entire industrial chain, currently serving over 100 global medical clients. Grounded in the philosophy of “anti-adhesion and promoting healing,” the Alexer® series is already trusted by nearly 1,000 hospitals in China.
The successful debut at WHX Dubai 2026 marks the official launch of SLK Medical’s strategic layout for the Middle East and Africa (MEA). Moving forward, the company will increase investment in international registrations and localized services to continue upgrading global wound care standards.
About SLK Medical
SLK Medical is a high-tech enterprise dedicated to advanced wound care solutions, particularly for sensitive skin and chronic wounds. With a robust R&D, production, and sales infrastructure, the company exports a wide range of products—including foam dressings, post-op dressings, and scar repair solutions—to over 20 countries and regions worldwide.
